Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Nectar Lifesciences Legal & Regulatory

Nectar Lifesciences Ltd announced the conclusion of income tax litigation for Assessment Year 2017-18. Following directions from the Punjab and Haryana High Court, the Deputy Commissioner of Income Tax passed an order in favor of the company on March 31, 2026. The matter stands fully concluded with no financial implications or claims.

Source

BSE filing, NSE: NECLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nectar Lifesciences Ltd: key numbers

Share price
₹10.34
Market cap
₹231.9 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-0.9×Sector 46.1×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nectar Lifesciences Ltd

All →

Other legal & regulatory announcements

All →